Last updated: 2026-09-16 12:38:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Rocket One Inc. (RKTO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0,74, with a market capitalisation of $16,71M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,62 to $2,45. This page covers its latest market performance, valuation, price trends and company information.
$16,71M | |
$0,73 | |
$2,45 | |
$0,62 | |
$0,74 | |
18,78K | |
3,19M | |
-- | |
$2,45 | |
$0,62 | |
-- | |
-- |
Rocket One Inc. (RKTO) is trading at $0,74 in pre-market trading as of 2026-09-16 12:19:00, down 0,15% ($0,00) from the previous close of $0,74
Pre-market trading shows how investors are pricing RKTO before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Rocket One Inc. (RKTO) moved from $0,69 to $0,74, representing a gain of 6,01% ($0,04).
The stock traded between $0,62 and $0,76 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 321,67 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 6,4%
RKTO is currently trading at $0,74, placing it 6,4% of the way from its 52-week low of $0,62 to its 52-week high of $2,45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Rocket One Inc is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space platforms, and defense systems. The company also intends to pursue opportunities related to nano-launch systems and nanosatellite deployment. In addition, its biotechnology operations, conducted through a wholly owned subsidiary, include development programs such as HT-001, HT-KIT, HT-ALZ, and a GDNF-based metabolic program.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 3 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Rocket One Inc. (RKTO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.